Company Filing History:
Years Active: 2014-2016
Title: Innovator David L. Tefft: Pioneering Genetic Variant Database Technologies
Introduction
David L. Tefft, an esteemed inventor based in Malden, MA, has made significant contributions to the field of genetics through his innovative work in genetic variant databases. With a total of two patents to his name, Tefft has focused his expertise on the complex relationship between genetic variations and their implications for hereditary disorders.
Latest Patents
Tefft's latest inventions revolve around a sophisticated system for describing polymorphisms or genetic variants. His patented technology provides a framework for detailing mutations and their interrelationships through the creation of variant objects and variant relation objects. Each of these objects serves as an instance of an abstract class of genomic features, allowing for the incorporation of multiple related elements. This innovative approach not only stores essential genetic disorder information but also utilizes genetic test results to generate informative reports based on identified variants or polymorphisms within a patient's genetic material.
Career Highlights
Currently, David L. Tefft is associated with Good Start Genetics, Inc., a company recognized for its advancements in genetic testing and analysis. His role at the company reflects his commitment to enhancing the understanding of genetic variations and their clinical relevance. Through his contributions, he aims to revolutionize how genetic information is interpreted and utilized in medical contexts.
Collaborations
Tefft's innovative journey is supported by notable colleagues, including Marcia M. Nizzari and Benjamin H. Breton. Collaborating with such talented professionals underscores the importance of teamwork in advancing technological breakthroughs in genetics, as they work together to develop innovative solutions for genetic testing.
Conclusion
David L. Tefft stands out as an influential figure in the realm of genetic innovations. His patents not only demonstrate a deep understanding of genetic polymorphisms but also highlight the potential of technology to improve patient care through better genetic insights. His ongoing work promises to yield even greater advancements for the future of genetic research and its applications in healthcare.